BIRC5 and urinary bladder cancer: The aim of this study was to develop a new ELISA for the quantification of survivin in urine samples and to evaluate the performance of the ELISA in combination with UBC®Rapid for urine-based detection of bladder cancer, especially high-grade tumors.